Alkermes’ Corporate Presentation to be Webcast at JPMorgan Annual Healthcare Conference

Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by JPMorgan on Wednesday, January 14, 2009 at 12:30 p.m. EST (9:30 a.m. PST). David Broecker, CEO of Alkermes, will provide a strategic overview of the company and present the company’s corporate goals for calendar 2009. The presentation will be webcast from the Westin St. Francis Hotel in San Francisco, California and may be accessed under the investor relations tab at www.alkermes.com. The presentation will be archived for 30 days.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes developed, manufactures and commercializes VIVITROL^® for alcohol dependence and manufactures RISPERDAL^® CONSTA^® for schizophrenia. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.